RxDoctor Payments Data

Colin Dias, MD

Psychiatry · Agoura Hills, CANPI 1811029168

Payments from drug & device makers

$1,346in general payments, 2019–2025

Across 61 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$452
  • Teva Pharmaceuticals USA, Inc.$250
  • Sunovion Pharmaceuticals Inc.$156
  • Johnson & Johnson$136
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$95
  • E.r. Squibb & Sons, L.L.C.$86
  • plus $172 from 7 others

What the payments were for

  • Food & beverage$1,18888%
  • Education$15812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,346 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$100,737
Medicare patients
75
Services billed
853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole15$48,111
TrintellixVortioxetine Hydrobromide13$6,396
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl40$5,745
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine89$2,013
Gabapentin169$1,645
Alprazolam158$1,523
Clonazepam227$1,510
Bupropion XlBupropion Hcl110$1,309
Desvenlafaxine Succinate ErDesvenlafaxine Succinate40$1,180
Divalproex Sodium ErDivalproex Sodium19$1,088
Trazodone Hcl157$1,070
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine34$946
Quetiapine Fumarate115$931
Buprenorphine Hcl24$797
Duloxetine Hcl47$762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$16$48,11115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Agoura Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →